"PLASMA FROM SARS-COV-2 NAIVE, COVID-19 VACCINATED SUBJECTS" THE PURPOSE OF THIS MODIFICATION IS TO: (1) AMEND THE COLLECTION WINDOW AND COMPLETION WINDOW; AND (2) ADD AN ADDITIONAL GOVERNMENT POINT-OF-CONTACT.
- Funded by Biomedical Advanced Research and Development Authority (BARDA)
- Total publications:0 publications
Grant number: 75A50121P00045
Grant search
Key facts
Disease
COVID-19Start & end year
20212022Known Financial Commitments (USD)
$537,000Funder
Biomedical Advanced Research and Development Authority (BARDA)Research Location
United States of AmericaLead Research Institution
SAN DIEGO BLOOD BANKResearch Priority Alignment
N/A
Research Category
13Research Subcategory
N/ASpecial Interest Tags
N/AStudy Type
Not applicableClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
"PLASMA FROM SARS-COV-2 NAIVE, COVID-19 VACCINATED SUBJECTS" THE PURPOSE OF THIS MODIFICATION IS TO: (1) AMEND THE COLLECTION WINDOW AND COMPLETION WINDOW; AND (2) ADD AN ADDITIONAL GOVERNMENT POINT-OF-CONTACT.